Evidence map›Paper›PMID 35025017›Full record

ArticleJournal of fluorescence2022

Establishment of Galectin-3 Time-resolved Fluoroimmunoassay and its Application in Idiopathic Membranous Nephropathy.

Xiaomei Yu, Lingli Chen, Bo Lin, Li Zhang, Xue Yang, Xiaobin Liu, Pengguo Xia, Yueming Liu, Shaoxiong Zheng, Xiumei Zhou and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Xiaomei Yu *College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Lingli Chen *College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Bo Lin *Zhejiang Provincial People's Hospital, Hangzhou, China.
Li ZhangCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Xue YangWuxi People's Hospital, affiliated to Nanjing Medical University, Wuxi, China.
Xiaobin LiuWuxi People's Hospital, affiliated to Nanjing Medical University, Wuxi, China.
Pengguo XiaCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Yueming LiuZhejiang Provincial People's Hospital, Hangzhou, China.
Shaoxiong ZhengCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Xiumei ZhouCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Yigang WangCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Yuan QinCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Liang WangWuxi People's Hospital, affiliated to Nanjing Medical University, Wuxi, China.
Zhigang HuWuxi People's Hospital, affiliated to Nanjing Medical University, Wuxi, China.
Qiang HeZhejiang Provincial People's Hospital, Hangzhou, China.
Biao HuangCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China. jswxhb@163.com.ORCID http://orcid.org/0000-0003-1883-0670
Zhejiang Sci-Tech University · CNWuxi People's Hospital · CNZhejiang Provincial People's Hospital · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to establish a time-resolved fluorescent immunoassay (TRFIA) for the detection of serum Galectin-3 (Gal-3) and apply this method to evaluate the clinical significance of serum Gal-3 in predicting Idiopathic Membranous Nephropathy (IMN) progression. The Gal-3-TRFIA was established using the double antibody sandwich method, with the capture antibodies coated on a 96-well microplate and the detection antibodies chelated with Europium (III) (Eu

Indexed as

AntibodiesDisease ProgressionEnzyme-Linked Immunosorbent AssayFluoroimmunoassayGalectin 3Glomerulonephritis, MembranousHumansProspective StudiesSensitivity and SpecificityTime FactorsAntibodiesGalectin 3DiagnosisFluoroimmunoassayGalectin-3Idiopathic membranous glomerulonephritis

Identifiers

PMID35025017
OpenAlexW4220875895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.